Telangana's Aspiration in Life Sciences
The Government of Telangana has showcased its ambition to become one of the leading players in the global life sciences sector with its newly introduced policy for 2026-30. This ambitious initiative aims to position Telangana among the top five global life sciences clusters by the year 2030. With a target of USD 25 billion in investments, this transformative policy endeavors to shift the state's focus from traditional manufacturing towards innovation-driven growth.
Key Highlights of the Next-Gen Life Sciences Policy
The Next-Gen Life Sciences Policy articulates a strategic shift aimed at enhancing value through innovation and developing a robust life sciences hub. It outlines a vision to create 500,000 high-quality jobs while integrating more deeply into international life sciences supply chains. This commitment signals a substantial evolution from a dependence on scale-led manufacturing to fostering an ecosystem where pioneering ideas and advanced therapies flourish.
Enhancing Research and Development
Telangana's growing reputation as a hub for life sciences is bolstered by the expansion of renowned global organizations in Hyderabad. Companies like Amgen, Sanofi, and Bristol Myers Squibb have chosen to establish robust R&D and digital capabilities here, a testament to the state’s commitment to nurturing scientific talent and supporting advanced technological frameworks.
Investment and Infrastructure Development
The policy emphasizes building a globally competitive infrastructure across various life sciences sectors, including the Green Pharma City and the expansion of Genome Valley. These developments are essential in supporting the creation of a conducive environment where innovative life sciences initiatives can thrive. A significant part of this infrastructure investment also includes the establishment of the Telangana School of Life Sciences, which is designed to cultivate future leaders in the field.
Aiming for Transformational Change
Telangana's Next-Gen Life Sciences Policy is not just a regulatory framework; it represents a large-scale commitment to ensure that the state transitions from being a critical player in global supply chains to becoming a pioneer of innovative therapies and solutions in the life sciences landscape.
Chief Minister Mr. A. Revanth Reddy highlighted the government's strategy during the policy's global unveiling, underscoring the importance of cross-border collaboration and innovation in driving health outcomes that make a global impact.
Focus on Advanced Manufacturing
The policy sets a clear focus on advanced manufacturing techniques, prioritizing cutting-edge areas such as cell and gene therapies, precision fermentation, and advanced drug delivery systems. This strategy aims not only to enhance clinical research and pharmaceutical services but also to bolster the diagnostics and digital health sectors, reinforcing Telangana's position as an attractive destination for international life sciences enterprises.
Long-term Vision and Sustainability
The implementation of this policy is supported by a dedicated Life Sciences Innovation Fund, scalable up to INR 1,000 crore (USD 100 million). This fund aims to foster early-stage innovation, attract private investment, and promote deep-tech ventures. As Telangana evolves into a comprehensive life sciences environment, the policy not only positions it favorably within global markets but also strengthens its existing supply chains.
About Telangana Life Sciences
Over the past two decades, Telangana has developed into a full-spectrum life sciences ecosystem encompassing everything from research to advanced manufacturing. Today, the state houses over 2,000 life sciences companies and boasts one of the highest numbers of USFDA-approved pharmaceutical facilities in the world. As a result, Telangana is now a critical manufacturer of the vaccines needed to meet one-third of global demand, playing a fundamental role in international healthcare supply chains.
Frequently Asked Questions
What is the main goal of Telangana's Next-Gen Life Sciences Policy?
The main goal is to position Telangana among the top five global life sciences clusters by 2030, targeting significant investments and job creation.
How much investment is Telangana targeting with this new policy?
Telangana is targeting USD 25 billion in investments under the new life sciences policy.
What sectors does the new policy focus on?
The policy emphasizes advanced manufacturing, innovative therapies, and the entire spectrum from discovery to clinical development.
What supporting infrastructure will be developed?
Infrastructure developments include the Green Pharma City and Genome Valley, aimed at enhancing the life sciences ecosystem.
How does the policy aim to foster innovation?
The policy includes a Life Sciences Innovation Fund to encourage early-stage ventures and attract investment into deep-tech innovations.
